Solicitation of Information and Recommendations for Supplementing the Guidance Provided in the Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs, 69452-69453 [2010-28366]
Download as PDF
<![CDATA[
69452
Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Clinical Oncology and
Chemoprevention.
Date: December 1, 2010.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Sharon K. Gubanich, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 435–
1767, gubanics@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–28468 Filed 11–10–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSKH9S0YB1PROD with NOTICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Mar<15>2010
18:02 Nov 10, 2010
Jkt 223001
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Behavioral Aspects of HIV/AIDS.
Date: December 3, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mark P. Rubert, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1775, rubertm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–28469 Filed 11–10–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
November 22, 2010, 1:30 p.m. to
November 22, 2010, 5 p.m., National
Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892 which was
published in the Federal Register on
October 20, 2010, 75 FR 64736.
The meeting will be held November
29, 2010. The meeting time and location
remain the same.
The meeting is closed to the public.
Dated: November 4, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–28467 Filed 11–10–10; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; B Cell Responses.
Date: January 11, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Lynn Rust, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, NIAID/
NIH/DHHS, Room 3120, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892,
301–402–3938, lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 4, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–28459 Filed 11–10–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Inspector General
Solicitation of Information and
Recommendations for Supplementing
the Guidance Provided in the Special
Advisory Bulletin on the Effect of
Exclusion from Participation in Federal
Health Care Programs
Office of Inspector General
(OIG), HHS.
ACTION: Notice.
AGENCY:
E:\FR\FM\12NON1.SGM
12NON1
Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices
This notice informs the public
that the Office of Inspector General
(OIG) intends to update the Special
Advisory Bulletin on the Effect of
Exclusion from Participation in Federal
Health Care Programs (64 FR 52791;
September 30, 1999) and solicits input
from the public for OIG to consider in
developing the updated bulletin.
DATES: To assure consideration, public
comments must be delivered to the
address provided below by no later than
5 p.m. on January 11, 2011.
ADDRESSES: In commenting, please refer
to file code OIG–115–N. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
three ways (no duplicates, please):
• Electronically. You may submit
electronic comments on specific
recommendations and proposals
through the Federal eRulemaking Portal
at https://www.regulations.gov.
(Attachments should be in Microsoft
Word, if possible.)
• By regular, express, or overnight
mail. You may send written comments
to the following address: Office of
Inspector General, Department of Health
and Human Services, Attention: OIG–
115–N, Room 5541, Cohen Building,
330 Independence Avenue, SW.,
Washington, DC 20201. Please allow
sufficient time for mailed comments to
be received before the close of the
comment period.
• By hand or courier. If you prefer,
you may deliver, by hand or courier,
your written comments before the close
of the comment period to Office of
Inspector General, Department of Health
and Human Services, Cohen Building,
330 Independence Avenue, SW.,
Washington, DC 20201. Because access
to the interior of the Cohen Building is
not readily available to persons without
Federal Government identification,
commenters are encouraged to schedule
their delivery with one of our staff
members at (202) 619–1343.
For information on viewing public
comments, please see the
Supplementary Information section.
FOR FURTHER INFORMATION CONTACT:
Patrice Drew, Department of Health and
Human Services, Office of Inspector
General, Office of External Affairs, (202)
619–1368.
SUPPLEMENTARY INFORMATION:
Submitting Comments: We welcome
comments from the public on this
Special Advisory Bulletin on the Effect
of Exclusion from Participation in
Federal Health Care Programs. Please
assist us by referencing the file code
OIG–115–N.
mstockstill on DSKH9S0YB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:23 Nov 10, 2010
Jkt 223001
Inspection of Public Comments: All
comments received before the end of the
comment period are available for
viewing by the public. All comments
will be posted on https://
www.regulations.gov as soon as possible
after they have been received.
Comments received timely will also be
available for public inspection as they
are received at Office of Inspector
General, Department of Health and
Human Services, Cohen Building, 330
Independence Avenue, SW.,
Washington, DC 20201, Monday
through Friday from 8:30 a.m. to 4 p.m.
To schedule an appointment to view
public comments, phone (202) 401–
2206.
Background
PO 00000
Frm 00058
Dated: November 5, 2010.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2010–28366 Filed 11–10–10; 8:45 am]
BILLING CODE 4152–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5374–N–21]
Buy American Exceptions Under the
American Recovery and Reinvestment
Act of 2009
Office of the Assistant
Secretary for Public and Indian
Housing, HUD.
ACTION: Notice.
AGENCY:
In accordance with the
American Recovery and Reinvestment
Act of 2009 (Pub. L. 111–05, approved
February 17, 2009) (Recovery Act), and
implementing guidance of the Office of
Management and Budget (OMB), this
notice advises that certain exceptions to
the Buy American requirement of the
Recovery Act have been determined
applicable for work using Capital Fund
Recovery Formula and Competition
(CFRFC) grant funds. Specifically, an
exception was granted to the Housing
Authority of the County of Cook (HACC)
for the purchase and installation of
through-the-wall air conditioning units
and Ground Fault Circuit Interrupter
(GFCI) outlets for the Riverdale Senior
Apartments project.
FOR FURTHER INFORMATION CONTACT:
Dominique G. Blom, Deputy Assistant
Secretary for Public Housing
Investments, Office of Public Housing
Investments, Office of Public and Indian
Housing, Department of Housing and
Urban Development, 451 7th Street,
SW., Room 4130, Washington, DC,
20410–4000, telephone number 202–
402–8500 (this is not a toll-free
number). Persons with hearing- or
speech-impairments may access this
number through TTY by calling the tollfree Federal Information Relay Service
at 800–877–8339.
SUPPLEMENTARY INFORMATION: Section
1605(a) of the Recovery Act provides
that none of the funds appropriated or
made available by the Recovery Act may
be used for a project for the
construction, alteration, maintenance, or
repair of a public building or public
work unless all of the iron, steel, and
manufactured goods used in the project
are produced in the United States.
Section 1605(b) provides that the Buy
American requirement shall not apply
in any case or category in which the
head of a Federal department or agency
SUMMARY:
The Special Advisory Bulletin on the
Effect of Exclusion from Participation in
Federal Health Care Programs contains
guidance which has proven to be
extremely important to excluded
individuals and to all of those in the
health care industry who are concerned
with compliance. The health care
industry and health care professionals
have now had more than a decade of
experience with the ramifications of
exclusion since OIG first published this
bulletin in 1999. With time it has
become even more apparent that
exclusion has a significant impact, not
only on those who have been excluded
but also on entities that have employed
or contracted with excluded persons
and been faced with liability for
overpayments and civil monetary
penalties as a result. As OIG’s
compliance and enforcement activities
in this area have increased, many health
care providers have discovered that they
employ excluded individuals and have
self-disclosed to the OIG. Many health
care providers have also sought to
design compliance programs that will
minimize the risk of submitting claims
to a Federal health care program for
items or services furnished, ordered, or
prescribed by an excluded individual.
In considering the content of the Special
Advisory Bulletin, OIG is soliciting
comments, recommendations, and other
suggestions from concerned parties and
organizations on how best to
supplement the guidance provided in
the Special Advisory Bulletin to address
relevant issues and to provide useful
guidance to the industry. For example,
OIG seeks comments on areas in which
clarification and further guidance on the
effect of exclusion may be helpful.
Fmt 4703
Sfmt 4703
69453
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69452-69453]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28366]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Inspector General
Solicitation of Information and Recommendations for Supplementing
the Guidance Provided in the Special Advisory Bulletin on the Effect of
Exclusion from Participation in Federal Health Care Programs
AGENCY: Office of Inspector General (OIG), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 69453]]
SUMMARY: This notice informs the public that the Office of Inspector
General (OIG) intends to update the Special Advisory Bulletin on the
Effect of Exclusion from Participation in Federal Health Care Programs
(64 FR 52791; September 30, 1999) and solicits input from the public
for OIG to consider in developing the updated bulletin.
DATES: To assure consideration, public comments must be delivered to
the address provided below by no later than 5 p.m. on January 11, 2011.
ADDRESSES: In commenting, please refer to file code OIG-115-N. Because
of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
You may submit comments in one of three ways (no duplicates,
please):
Electronically. You may submit electronic comments on
specific recommendations and proposals through the Federal eRulemaking
Portal at https://www.regulations.gov. (Attachments should be in
Microsoft Word, if possible.)
By regular, express, or overnight mail. You may send
written comments to the following address: Office of Inspector General,
Department of Health and Human Services, Attention: OIG-115-N, Room
5541, Cohen Building, 330 Independence Avenue, SW., Washington, DC
20201. Please allow sufficient time for mailed comments to be received
before the close of the comment period.
By hand or courier. If you prefer, you may deliver, by
hand or courier, your written comments before the close of the comment
period to Office of Inspector General, Department of Health and Human
Services, Cohen Building, 330 Independence Avenue, SW., Washington, DC
20201. Because access to the interior of the Cohen Building is not
readily available to persons without Federal Government identification,
commenters are encouraged to schedule their delivery with one of our
staff members at (202) 619-1343.
For information on viewing public comments, please see the
Supplementary Information section.
FOR FURTHER INFORMATION CONTACT: Patrice Drew, Department of Health and
Human Services, Office of Inspector General, Office of External
Affairs, (202) 619-1368.
SUPPLEMENTARY INFORMATION:
Submitting Comments: We welcome comments from the public on this
Special Advisory Bulletin on the Effect of Exclusion from Participation
in Federal Health Care Programs. Please assist us by referencing the
file code OIG-115-N.
Inspection of Public Comments: All comments received before the end
of the comment period are available for viewing by the public. All
comments will be posted on https://www.regulations.gov as soon as
possible after they have been received. Comments received timely will
also be available for public inspection as they are received at Office
of Inspector General, Department of Health and Human Services, Cohen
Building, 330 Independence Avenue, SW., Washington, DC 20201, Monday
through Friday from 8:30 a.m. to 4 p.m. To schedule an appointment to
view public comments, phone (202) 401-2206.
Background
The Special Advisory Bulletin on the Effect of Exclusion from
Participation in Federal Health Care Programs contains guidance which
has proven to be extremely important to excluded individuals and to all
of those in the health care industry who are concerned with compliance.
The health care industry and health care professionals have now had
more than a decade of experience with the ramifications of exclusion
since OIG first published this bulletin in 1999. With time it has
become even more apparent that exclusion has a significant impact, not
only on those who have been excluded but also on entities that have
employed or contracted with excluded persons and been faced with
liability for overpayments and civil monetary penalties as a result. As
OIG's compliance and enforcement activities in this area have
increased, many health care providers have discovered that they employ
excluded individuals and have self-disclosed to the OIG. Many health
care providers have also sought to design compliance programs that will
minimize the risk of submitting claims to a Federal health care program
for items or services furnished, ordered, or prescribed by an excluded
individual. In considering the content of the Special Advisory
Bulletin, OIG is soliciting comments, recommendations, and other
suggestions from concerned parties and organizations on how best to
supplement the guidance provided in the Special Advisory Bulletin to
address relevant issues and to provide useful guidance to the industry.
For example, OIG seeks comments on areas in which clarification and
further guidance on the effect of exclusion may be helpful.
Dated: November 5, 2010.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2010-28366 Filed 11-10-10; 8:45 am]
BILLING CODE 4152-01-P
